Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

COVID-19 Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global COVID-19 diagnostics market is currently experiencing strong growth. Looking forward, IMARC Group expects the market to exhibit moderate growth in the coming years.

COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.

The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth. Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global COVID-19 diagnostics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product type, sample type, test type, mode and end use.

Breakup by Product Type:

  • Reagents and Kits
  • Instruments
  • Others
     

Breakup by Sample Type:

  • Nasopharyngeal Swabs
  • Oropharyngeal Swabs
  • Nasal Swabs
  • Blood
  • Others
     

Breakup by Test Type:

  • Molecular (RT-PCR) Testing
  • Antigen-based Testing
  • Antibody (Serology) Testing
  • Others
     

Breakup by Mode:

  • Point-of-Care (PoC)
  • Non-Point-of-Care (Non-PoC)
     

Breakup by End Use:

  • Laboratories
  • Hospitals
  • Diagnostic Centers and Clinics
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Product Type, Sample Type, Test Type, Mode, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global COVID-19 diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the sample type?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the mode?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global COVID-19 diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global COVID-19 Diagnostics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product Type
    6.1    Reagents and Kits
        6.1.1 Market Trends and Forecast
    6.2    Instruments
        6.2.1 Market Trends and Forecast
    6.3    Others
        6.3.1 Market Trends and Forecast
7    Market Breakup by Sample Type
    7.1    Nasopharyngeal Swabs
        7.1.1 Market Trends and Forecast
    7.2    Oropharyngeal Swabs
        7.2.1 Market Trends and Forecast
    7.3    Nasal Swabs
        7.3.1 Market Trends and Forecast
    7.4    Blood
        7.4.1 Market Trends and Forecast
    7.5    Others
        7.5.1 Market Trends and Forecast
8    Market Breakup by Test Type
    8.1    Molecular (RT-PCR) Testing
        8.1.1 Market Trends and Forecast
    8.2    Antigen-based Testing
        8.2.1 Market Trends and Forecast
    8.3    Antibody (Serology) Testing
        8.3.1 Market Trends and Forecast
    8.4    Others
        8.4.1 Market Trends and Forecast
9    Market Breakup by Mode
    9.1    Point-of-Care (PoC)
        9.1.1 Market Trends and Forecast
    9.2    Non-Point-of-Care (Non-PoC)
        9.2.1 Market Trends and Forecast
10    Market Breakup by End Use
    10.1    Laboratories
        10.1.1 Market Trends and Forecast
    10.2    Hospitals
        10.2.1 Market Trends and Forecast
    10.3    Diagnostic Centers and Clinics
        10.3.1 Market Trends and Forecast
    10.4    Others
        10.4.1 Market Trends and Forecast
11    Market Breakup by Region
    11.1    North America
        11.1.1 United States
           11.1.1.1 Market Trends and Forecast
        11.1.2 Canada
           11.1.2.1 Market Trends and Forecast
    11.2    Asia-Pacific
        11.2.1 China
           11.2.1.1 Market Trends and Forecast
        11.2.2 Japan
           11.2.2.1 Market Trends and Forecast
        11.2.3 India
           11.2.3.1 Market Trends and Forecast
        11.2.4 South Korea
           11.2.4.1 Market Trends and Forecast
        11.2.5 Australia
           11.2.5.1 Market Trends and Forecast
        11.2.6 Indonesia
           11.2.6.1 Market Trends and Forecast
        11.2.7 Others
           11.2.7.1 Market Trends and Forecast
    11.3    Europe
        11.3.1 Germany
           11.3.1.1 Market Trends and Forecast
        11.3.2 France
           11.3.2.1 Market Trends and Forecast
        11.3.3 United Kingdom
           11.3.3.1 Market Trends and Forecast
        11.3.4 Italy
           11.3.4.1 Market Trends and Forecast
        11.3.5 Spain
           11.3.5.1 Market Trends and Forecast
        11.3.6 Russia
           11.3.6.1 Market Trends and Forecast
        11.3.7 Others
           11.3.7.1 Market Trends and Forecast
    11.4    Latin America
        11.4.1 Brazil
           11.4.1.1 Market Trends and Forecast
        11.4.2 Mexico
           11.4.2.1 Market Trends and Forecast
        11.4.3 Others
           11.4.3.1 Market Trends and Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends and Forecast
        11.5.2 Market Breakup by Country
12    SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13    Value Chain Analysis
14    Porters Five Forces Analysis

    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15    Price Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Abbott Laboratories
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio
           16.3.1.3 Financials
           16.3.1.4 SWOT Analysis
        16.3.2    Becton Dickinson and Company
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
           16.3.2.3 Financials
           16.3.2.4 SWOT Analysis
        16.3.3    bioMérieux SA
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio
           16.3.3.3 Financials
           16.3.3.4 SWOT Analysis
        16.3.4    Bio-Rad Laboratories
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
           16.3.4.3 Financials
           16.3.4.4 SWOT Analysis
        16.3.5    Danaher Corporation
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio
           16.3.5.3 Financials
           16.3.5.4 SWOT Analysis
        16.3.6    F. Hoffman-La Roche Ltd. (Roche Holding AG)
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
           16.3.6.3 Financials
        16.3.7    Luminex Corporation
           16.3.7.1 Company Overview
           16.3.7.2 Product Portfolio
           16.3.7.3 Financials
           16.3.7.4 SWOT Analysis
        16.3.8    PerkinElmer Inc.
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
           16.3.8.3 Financials
           16.3.8.4 SWOT Analysis
        16.3.9    Quest Diagnostics Incorporated
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
           16.3.9.3 Financials
           16.3.9.4 SWOT Analysis
        16.3.10    Robert Bosch GmbH
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio
        16.3.11    Seegene Inc.
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio
           16.3.11.3 Financials
        16.3.12    Siemens Aktiengesellschaft
           16.3.12.1 Company Overview
           16.3.12.2 Product Portfolio
           16.3.12.3 Financials
           16.3.12.4 SWOT Analysis
        16.3.13    Thermo Fisher Scientific Inc.
           16.3.13.1 Company Overview
           16.3.13.2 Product Portfolio
           16.3.13.3 Financials
           16.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: COVID-19 Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: COVID-19 Diagnostics Market: Sales Value (in Billion US$), 2020-2026
Figure 3: Global: COVID-19 Diagnostics Market: Breakup by Product Type (in %), 2020
Figure 4: Global: COVID-19 Diagnostics Market: Breakup by Sample Type (in %), 2020
Figure 5: Global: COVID-19 Diagnostics Market: Breakup by Test Type (in %), 2020
Figure 6: Global: COVID-19 Diagnostics Market: Breakup by Mode (in %), 2020
Figure 7: Global: COVID-19 Diagnostics Market: Breakup by End Use (in %), 2020
Figure 8: Global: COVID-19 Diagnostics Market: Breakup by Region (in %), 2020
Figure 9: Global: COVID-19 Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2020-2026
Figure 10: Global: COVID-19 Diagnostics (Instruments) Market: Sales Value (in Million US$), 2020-2026
Figure 11: Global: COVID-19 Diagnostics (Other Product Types) Market: Sales Value (in Million US$), 2020-2026
Figure 12: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market: Sales Value (in Million US$), 2020-2026
Figure 13: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market: Sales Value (in Million US$), 2020-2026
Figure 14: Global: COVID-19 Diagnostics (Nasal Swabs) Market: Sales Value (in Million US$), 2020-2026
Figure 15: Global: COVID-19 Diagnostics (Blood) Market: Sales Value (in Million US$), 2020-2026
Figure 16: Global: COVID-19 Diagnostics (Other Sample Types) Market: Sales Value (in Million US$), 2020-2026
Figure 17: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market: Sales Value (in Million US$), 2020-2026
Figure 18: Global: COVID-19 Diagnostics (Antigen-based Testing) Market: Sales Value (in Million US$), 2020-2026
Figure 19: Global: COVID-19 Diagnostics (Antibody Testing- Serology) Market: Sales Value (in Million US$), 2020-2026
Figure 20: Global: COVID-19 Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2020-2026
Figure 21: Global: COVID-19 Diagnostics (Point-of-Care- PoC) Market: Sales Value (in Million US$), 2020-2026
Figure 22: Global: COVID-19 Diagnostics (Non-Point-of-Care- Non-PoC) Market: Sales Value (in Million US$), 2020-2026
Figure 23: Global: COVID-19 Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2020-2026
Figure 24: Global: COVID-19 Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2020-2026
Figure 25: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market: Sales Value (in Million US$), 2020-2026
Figure 26: Global: COVID-19 Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2020-2026
Figure 27: North America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 28: United States: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 29: Canada: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 30: Asia-Pacific: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 31: China: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 32: Japan: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 33: India: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 34: South Korea: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 35: Australia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 36: Indonesia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 37: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 38: Europe: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 39: Germany: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 40: France: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 41: United Kingdom: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 42: Italy: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 43: Spain: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 44: Russia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 45: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 46: Latin America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 47: Brazil: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 48: Mexico: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 49: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 50: Middle East and Africa: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2020-2026
Figure 51: Middle East and Africa: COVID-19 Diagnostics Market: Breakup by Country (in %), 2020
Figure 52: Global: COVID-19 Diagnostics Industry: SWOT Analysis
Figure 53: Global: COVID-19 Diagnostics Industry: Value Chain Analysis
Figure 54: Global: COVID-19 Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: COVID-19 Diagnostics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: COVID-19 Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 3: Global: COVID-19 Diagnostics Market Forecast: Breakup by Sample Type (in Million US$), 2021-2026
Table 4: Global: COVID-19 Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2021-2026
Table 5: Global: COVID-19 Diagnostics Market Forecast: Breakup by Mode (in Million US$), 2021-2026
Table 6: Global: COVID-19 Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2021-2026
Table 7: Global: COVID-19 Diagnostics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 8: Global: COVID-19 Diagnostics Market: Competitive Structure
Table 9: Global: COVID-19 Diagnostics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links